With a focus on understanding globally important infectious diseases, Colorado State University is home to world-renowned scientists and leaders researching vector-borne diseases, drug-resistant bacterium, and numerous viral diseases. The Infectious Disease Research Center (IDRC) provides a high quality research environment for developing new scientific discoveries, vaccines, methods of diagnosis, and therapeutic agents for infectious agents, including BSL-3 laboratories and BioMARC’s cGMP manufacturing infrastructure and expertise.
Our capabilities are built on a foundation of faculty-based research programs spanning decades. Much of our current research includes COVID-19, Tuberculosis, HIV, Dengue, Zika, Ebola, Malaria, Lyme Disease and other pathogens of interest from both an animal and human health perspective. Our mission, quite simply stated, is to defeat global health threats.
To that end, we have curated a list of technologies that we believe may be of value to those involved in mitigating the current COVID-19 pandemic in addition to numerous other infectious diseases that continually devastate populations worldwide.
COVID Innovation Note: Colorado State University has committed to technology licensing principles intended to facilitate and maximize access to university innovations that can address the COVID-19 pandemic. As part of the worldwide University technology transfer network, CSU is endorsing the licensing principles found at the Association of University Technology Managers (AUTM) website (COVID-19 Licensing Guidelines).
